The Impact of Rapid Virus Quantification in the Development and Manufacture of Advanced Therapies

BPI Contributor

September 26, 2019

20 Min View
The Impact of Rapid Virus Quantification in the Development and Manufacture of Advanced Therapies

Date: Sep 26, 2019

Duration: 20 Min

Already have an account?

This webcast features: Antje Schickert, Product Manager, Virus Analytics, Sartorius Stedim Biotech

Viral vectors, such as lenti- and adeno-associated viruses, are increasingly being used for the production of cell and gene therapies.  In-depth sample characterization and precise enumeration of total viral vectors is needed throughout the manufacturing process and particularly for the final formulation.  Learn how rapid accurate enumeration of the total virus provides timely information on titer leading to accelerated process development and increased efficiency of viral vector manufacturing.

Watch the recorded webcast below.

You May Also Like